Revenue
5Y CAGR −0.3%5Y CAGR −0.3%No quarters filed for this figure.
Form 4 transactions by trade date, as filed; latest on file 2026-11-04.
Fundamentals end at the last reported quarter; price and total return end at the latest close.
No quarters filed for this figure.
No quarters filed for this figure.
No quarters filed for this figure.
FY26: operating cash flow $6.9B, capex —
No quarters filed for this figure.
No quarters filed for this figure.
Takeda Pharmaceutical Co Ltd ADR is a sponsored American depositary receipt representing shares of Takeda Pharmaceutical Company Limited, a Japan-based pharmaceutical company. Takeda develops, manufactures, markets, and out-licenses prescription medicines across major therapeutic areas including gastroenterology, rare diseases, plasma-derived therapies, oncology, vaccines, and neuroscience. Its portfolio is centered on specialty treatments and biologic medicines used in hospital, clinic, and outpatient settings, with commercial operations spanning Japan, the United States, Europe, and other international markets. The company also supports research and development, regulatory activities, and global manufacturing for small-molecule and biologic products. Takeda Pharmaceutical Co Ltd ADR provides U.S. investors with access to a diversified healthcare business focused on drug discovery, clinical development, and worldwide pharmaceutical commercialization.
Tokyo, Japan·49,281 employees·Drug Manufacturers - Specialty & Generic·takeda.com·As of Oct 28, 2026
10 of the 193 ETFs ChartRow carries live hold TAK. The 8 largest positions, by the weight each fund filed in its latest SEC N-PORT report (Jun 26 to Aug 26).
| Fund | Name | Filed weight |
|---|---|---|
| EWJ | iShares MSCI Japan ETF | 1.1% |
| VPL | Vanguard FTSE Pacific ETF | 0.4% |
| VYMI | Vanguard International High Dividend Yield ETF | 0.3% |
| EFA | iShares MSCI EAFE ETF | 0.2% |
| VEA | Vanguard FTSE Developed Markets ETF | 0.2% |
| VEU | Vanguard FTSE All-World ex-US ETF | 0.1% |
| VXUS | Vanguard Total International Stock ETF | 0.1% |
| URTH | iShares MSCI World ETF | 0.1% |
| Ticker | Name | 1M | 1D |
|---|---|---|---|
| LLY | Eli Lilly and Company | +23.75% | +1.14% |
| JNJ | Johnson & Johnson | +14.94% | +0.79% |
| ABBV | AbbVie Inc. | +7.53% | +0.20% |
| UNH | UnitedHealth Group Incorporated Common Stock (DE) | +7.86% | +0.58% |
| MRK | Merck & Co. Inc. | +4.07% | +0.55% |
| NVS | Novartis AG | +12.70% | +0.16% |
| TMO | Thermo Fisher Scientific Inc. | +5.61% | +0.11% |
| AMGN | Amgen Inc. | +12.80% | -0.30% |